Transcriptional signature-derived bystander-activated CD8+ T cells were enriched in patients with mild disease, while those from TCR-activated cells were associated with severe COVID-19 (Figure 5F), again consistent with widespread early bystander activation in the CD8+ T cell population in patients destined to have good disease outcomes. The gene discussed is CD8A; the disease is COVID-19.